Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteogenesis imperfecta

M S Kocher1, F Shapiro

  • 1Department of Orthopaedic Surgery, Children's Hospital, Boston, MA 02115, USA.

The Journal of the American Academy of Orthopaedic Surgeons
|July 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric anterior cruciate ligament tears: management and growth disturbances. A survey of EPOS and POSNA membership.

Journal of children's orthopaedics·2019
Same author

Woven bone overview: structural classification based on its integral role in developmental, repair and pathological bone formation throughout vertebrate groups.

European cells & materials·2019
Same author

Detecting ethanol and acetaldehyde by simple and ultrasensitive fluorimetric methods in compound foods.

Food chemistry·2016
Same author

Epiphyseal growth plate fracture-separations: a pathophysiologic approach.

Orthopedics·2014
Same author

Acetabular changes associated with avascularnecrosis of the femoral head in a piglet model.

Bone & joint research·2014
Same author

Reply to the Letter to the editor: Labral injuries of the hip in rowers.

Clinical orthopaedics and related research·2014
Same journal

Childhood Opportunity Index and Severity at Diagnosis of Developmental Dysplasia of the Hip.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Management of Intraoperative Fractures During Primary Direct Anterior Total Hip Arthroplasty.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Sports Medicine Patients Accurately Predict Their Pain Tolerance.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Advocacy for Medical Students Applying to Orthopaedic Surgery: A Practical Guide for Attending Physicians.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Bridging the Gap: Social Media as an Untapped Tool in Orthopaedic Trauma Fellowship Recruitment.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same journal

Surgical Fixation Versus Cast Immobilization for Adults With Bicortical Scaphoid Fractures: A Target Trial Emulation of the SWIFFT Trial.

The Journal of the American Academy of Orthopaedic Surgeons·2026
See all related articles

Osteogenesis imperfecta (OI) is a genetic bone disorder causing fragility due to type I collagen gene mutations. Treatment focuses on managing symptoms and improving function through a multidisciplinary approach.

Area of Science:

  • Genetics
  • Orthopedics
  • Connective Tissue Disorders

Background:

  • Osteogenesis imperfecta (OI) is a heterogeneous group of inherited connective tissue disorders.
  • Characterized by bone fragility resulting from mutations in type I collagen genes (COL1A1, COL1A2).
  • Manifests in tissues rich in type I collagen, including bone, dentin, and sclerae.

Purpose of the Study:

  • To provide a comprehensive overview of Osteogenesis Imperfecta.
  • To discuss the genetic basis, clinical manifestations, and diagnostic approaches.
  • To review current and potential therapeutic strategies, including gene therapy.

Main Methods:

  • Literature review of genetic, clinical, and radiological features of OI.
  • Analysis of identified mutations in COL1A1 and COL1A2 genes.

Related Experiment Videos

  • Evaluation of treatment outcomes and challenges.

    • Main Results:

    • Over 150 mutations in COL1A1 and COL1A2 genes have been identified.
    • OI presents a wide spectrum of severity, from lethal to clinically silent forms.
    • Current systemic treatments are largely ineffective or experimental; gene therapy faces technical hurdles.

    Conclusions:

    • Effective management of OI requires a multidisciplinary team approach tailored to disease severity and patient age.
    • Nonoperative orthopedic management is crucial for fracture prevention and locomotion enhancement.
    • Operative intervention is reserved for cases with significant functional impairment due to recurrent fractures or deformity.